Results 101 to 110 of about 2,377,916 (241)

Cardiotonics. Cardiac glycosides. Antiarrhythmic drugs

, 2021
The lecture contains description of main inotropic and antiarrhythmic preparations which are used in therapy of congestive and acute heart failure and different types of ...
Doroshenko, Oksana
core   +1 more source

Sodium-glucose transporter 2 inhibitors and their antiarrhythmic role: New insights and future perspective

Acta Marisiensis - Seria Medica
Sodium-glucose transporter 2 inhibitors have been identified as pleiotropic pharmacological agents with demonstrated efficacy in a wide range of pathologies.
Prația-Aron Diana-Ioana, Cozac Dan-Alexandru, Scridon Alina   +2 more
doaj   +1 more source

New possibilities of antiarrhythmic therapy of atrial fibrillation: A review

Терапевтический архив
Atrial fibrillation (AF) is the most common heart rhythm disorder. According to current recommendations, the treatment of AF includes 3 main directions: "A" – the appointment of anticoagulant therapy with an increased risk of thromboembolic complications,
Aida I. Tarzimanova, Alena Iu. Isaeva
doaj   +1 more source

Antiarrhythmic drug and antithrombotic therapy after catheter ablation between the AF recurrence and SR maintenance groups.

, 2018
Antiarrhythmic drug and antithrombotic therapy after catheter ablation between the AF recurrence and SR maintenance groups.
Dae-In Lee (5537753), Seung-Young Roh (4789593), Jong-Il Choi (2582920), Jinhee Ahn (4529095), Jaemin Shim (3183030), Dong-Hyeok Kim (5314817), Kwang-No Lee (5537750), Young-Hoon Kim (286883)   +7 more
core   +1 more source

A new approach to an old disease: Ageing, arrhythmogenic substrate and the role of risk‐factor modification in atrial fibrillation

Experimental Physiology, EarlyView.
Abstract Atrial fibrillation (AF) prevalence rises sharply with age due to two independent mechanisms. Ageing produces irreversible arrhythmogenic substrate changes through progressive fibrosis, cellular senescence and mitochondrial dysfunction, while modifiable risk factors such as obesity, hypertension, sleep apnoea, diabetes and alcohol use promote ...
Udit Thakur, Jonathan M. Kalman
wiley   +1 more source

Antiarrhythmic Therapy for Atrial Fibrillation [PDF]

, 2013
Antiarrhythmic therapy for atrial fibrillation comprises a broad range of medications that are used to prevent conversion from normal sinus rhythm to atrial fibrillation, as well as to control symptoms.
Tsu, Laura V.
core   +1 more source

TMEM16A Ca2+‐activated Cl− channel: Functional interactions with cytoskeletal and membrane‐associated proteins

The Journal of Physiology, EarlyView.
Abstract figure legend The calcium‐activated chloride (ClCa) channel TMEM16A (also known as ANO1) plays critical roles in ion transport, neurotransmission and smooth muscle contraction. Dysregulation of TMEM16A channel activity contributes to the development and progression of various diseases.
Hisao Yamamura, Rubii Kondo, Yoshiaki Suzuki, Yuji Imaizumi, Aya Yamamura   +4 more
wiley   +1 more source

Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis

BMC Cardiovascular Disorders
Background Catheter ablation and antiarrhythmic drug therapy are utilized for rhythm control in atrial fibrillation (AF), but their comparative effectiveness, especially with contemporary treatment modalities, remains undefined. We conducted a systematic
Subhash Chander, Roopa Kumari, Sindhu Luhana, Sheena Shiwlani, Om Parkash, FNU Sorath, Hong Yu Wang, Sam Tan, Zubair Rahaman, Yaqub Nadeem Mohammed, Abhi Chand Lohana, FNU Sakshi, Esha Vaish, FNU Sadarat   +13 more
doaj   +1 more source

antiarrhythmic pharmacotherapy during SARS-COV-2 pandemic

, 2021
This thesis offers a review of antiarrhythmic drugs with an emphasis on antiarrhythmic therapy during SARS-CoV-2 pandemic. Includes the general mechanisms causing arrhythmias with and without SARS-CoV-2 infection.
Meltzer, Maya Di
core  

Computational modelling of cardiac fibroblast signalling reveals a key role for Ca2+ in driving atrial fibrillation‐associated fibrosis

The Journal of Physiology, EarlyView.
Abstract figure legend A pre‐existing fibroblast signalling model was enhanced by integrating atrial‐specific components and reactions linked to atrial fibrosis and atrial fibrillation (AF). The analysis highlights the central role of Ca2⁺ signalling in driving profibrotic responses to AF‐relevant stimuli, angiotensin‐II and transforming growth factor ...
Najme Khorasani, Haibo Ni, Jeffrey J Saucerman, Dobromir Dobrev, Stefano Morotti, Eleonora Grandi   +5 more
wiley   +1 more source